SCHEMBL14723747

SCHEMBL14723747

CC(C)(C)OC(=O)Nc1ccc(-c2ccc(NC(=O)[C@@H]3CCCN3C(=O)OCC3c4ccccc4-c4ccccc43)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.54
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
LMNA P02545 2/20 0.49
KDM4E B2RXH2 1/20 0.49
KCNH2 Q12809 1/20 0.47
MDM2 Q00987 1/20 0.47
PABPC1 P11940 1/20 0.47
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
HSD17B10 Q99714 1/20 0.46
KDM1A O60341 1/20 0.45
RCOR1 Q9UKL0 1/20 0.45
NPSR1 Q6W5P4 3/20 0.45
JAK2 O60674 1/20 0.45
PTPN2 P17706 1/20 0.45
PTPN1 P18031 1/20 0.45
PTPN6 P29350 1/20 0.45
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13379481 0.92 NPC1 (0.52) NPC1MEN1KMT2ALMNAKDM4E
SCHEMBL31188287 0.91 NPC1 (0.57) NPC1MEN1KMT2ALMNAKDM4E
SCHEMBL18901985 0.85 NPC1 (0.51) NPC1MEN1KMT2ALMNAKDM4E
SCHEMBL27420162 0.84 KMT2A (0.47) NPC1MEN1KMT2ALMNAALDH1A1
SCHEMBL30877536 0.84 KMT2A (0.47) NPC1MEN1KMT2ALMNAALDH1A1
SCHEMBL26140160 0.82 KDM4E (0.54) NPC1LMNAKDM4EPABPC1ALDH1A1
SCHEMBL13230394 0.82 KDM4E (0.71) NPC1MEN1KMT2ALMNAKDM4E
SCHEMBL4229009 0.81 KMT2A (0.55) NPC1MEN1KMT2ALMNAKDM4E
SCHEMBL4229005 0.81 KMT2A (0.55) NPC1MEN1KMT2ALMNAKDM4E
SCHEMBL1752680 0.80 NPC1 (0.74) NPC1MEN1KMT2ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383094-B2 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials BRISTOL-MYERS SQUIBB COMPANY (US) 2013-02-26 US disclosed